Oct 26, 2023 / 07:00AM GMT
Operator
Welcome to the Novozymes conference call regarding the interim report for the first 9 months of 2023. (Operator Instructions)
Today, I am pleased to leave the word to Tobias Cornelius Björklund, Head of Investor Relations. Please begin your meeting.
Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR
Thank you, operator, and welcome, everyone, to Novozymes conference call for the first 9 months of 2023. My name is, as mentioned, Tobias Björklund, and I'm heading up Investor Relations here at Novozymes. At this call, our CEO, Ester Baiget; and our CFO, Lars Green, will review our performance and key events of the first 9 months of the year as well as the outlook for the full year. Also attending today's call are Tina Fanoe, EVP, Agriculture & Industrial Biosolutions; Amy Byrick, EVP, Strategy and Business Transformation; Anders Lund, EVP, Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research and Development. Then entire call will take about 60 minutes, including time for questions at the end.
Q3 2023 Novozymes A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot